Hillhouse Capital Group
8 Marina Boulevard, #28-01, Marina Bay Financial Centre Tower 1, Singapore, 018981
Overview
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Elegoo | May 2026Participated | $73 MSeries B | |
Axoft | Apr 2026Participated | $55 MSeries A | |
Earendil Labs | Mar 2026Participated | $787 MOther Equity | |
NOT A HOTEL | Feb 2026Participated | $66 MDebt | |
ZAST.AI | Feb 2026Led | $6 MSeries A | |
Angitia Biopharmaceuticals | Feb 2026Participated | $130 MSeries D | |
Third Arc Bio | Feb 2026Participated | $52 MSeries A | |
Tenpoint Therapeutics | Jan 2026Led | $235 MDebt | |
The Snow League | Nov 2025Participated | $15 MOther Equity | |
Dinii | Sep 2024Led | $50 MSeries B | |
Third Arc Bio | Jul 2024Led | $165 MSeries A | |
Orange Dental | Jan 2024Participated | $130 MSeries B | |
Elegoo | May 2026Participated | $73 MSeries B | |
Axoft | Apr 2026Participated | $55 MSeries A | |
Earendil Labs | Mar 2026Participated | $787 MOther Equity | |
NOT A HOTEL | Feb 2026Participated | $66 MDebt | |
ZAST.AI | Feb 2026Led | $6 MSeries A | |
Angitia Biopharmaceuticals | Feb 2026Participated | $130 MSeries D | |
Third Arc Bio | Feb 2026Participated | $52 MSeries A | |
Tenpoint Therapeutics | Jan 2026Led | $235 MDebt | |
The Snow League | Nov 2025Participated | $15 MOther Equity | |
Dinii | Sep 2024Led | $50 MSeries B | |
Third Arc Bio | Jul 2024Led | $165 MSeries A | |
Orange Dental | Jan 2024Participated | $130 MSeries B |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Series A | 4 | 2 |
| Series B | 5 | 10 |
| Series C+ | 7 | 6 |
| Other Equity | 3 | 4 |
| Debt | 1 | 1 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Feb '16 | 1 |
| Mar '16 | 0 |
| Apr '16 | 0 |
| May '16 | 0 |
| Jun '16 | 0 |
| Jul '16 | 0 |
| Aug '16 | 0 |
| Sep '16 | 0 |
| Oct '16 | 0 |
| Nov '16 | 0 |
| Dec '16 | 0 |
| Jan '17 | 0 |
| Feb '17 | 0 |
| Mar '17 | 0 |
| Apr '17 | 0 |
| May '17 | 0 |
| Jun '17 | 0 |
| Jul '17 | 1 |
| Aug '17 | 0 |
| Sep '17 | 0 |
| Oct '17 | 0 |
| Nov '17 | 1 |
| Dec '17 | 2 |
| Jan '18 | 0 |
| Feb '18 | 0 |
| Mar '18 | 1 |
| Apr '18 | 2 |
| May '18 | 1 |
| Jun '18 | 0 |
| Jul '18 | 3 |
| Aug '18 | 0 |
| Sep '18 | 0 |
| Oct '18 | 0 |
| Nov '18 | 1 |
| Dec '18 | 0 |
| Jan '19 | 1 |
| Feb '19 | 1 |
| Mar '19 | 0 |
| Apr '19 | 0 |
| May '19 | 0 |
| Jun '19 | 0 |
| Jul '19 | 0 |
| Aug '19 | 0 |
| Sep '19 | 0 |
| Oct '19 | 0 |
| Nov '19 | 0 |
| Dec '19 | 0 |
| Jan '20 | 1 |
| Feb '20 | 0 |
| Mar '20 | 0 |
| Apr '20 | 1 |
| May '20 | 0 |
| Jun '20 | 0 |
| Jul '20 | 1 |
| Aug '20 | 0 |
| Sep '20 | 0 |
| Oct '20 | 0 |
| Nov '20 | 1 |
| Dec '20 | 0 |
| Jan '21 | 0 |
| Feb '21 | 0 |
| Mar '21 | 0 |
| Apr '21 | 0 |
| May '21 | 0 |
| Jun '21 | 2 |
| Jul '21 | 3 |
| Aug '21 | 1 |
| Sep '21 | 0 |
| Oct '21 | 0 |
| Nov '21 | 0 |
| Dec '21 | 0 |
| Jan '22 | 1 |
| Feb '22 | 1 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 1 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 2 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 1 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 1 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 1 |
| Aug '24 | 0 |
| Sep '24 | 1 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 1 |
| Dec '25 | 0 |
| Jan '26 | 1 |
| Feb '26 | 4 |
| Mar '26 | 1 |
| Apr '26 | 1 |
| May '26 | 1 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 24 |
| Hardware & Robotics | 5 |
| Manufacturing | 5 |
| Food & Agriculture | 5 |
| Enterprise Software | 4 |
| Space & Frontier Tech | 4 |
| Consumer & Lifestyle | 4 |
| Networks, Cloud & Communication | 4 |
| E-Commerce & Retail | 3 |
| Transportation & Logistics | 3 |
| Fintech | 3 |
| Education & Workforce | 2 |
| Clean Energy & Sustainability | 2 |
| AI & Machine Learning | 2 |
| Social & Community Platforms | 2 |
| Travel & Hospitality | 1 |
| Cybersecurity & Privacy | 1 |
| AR/VR | 1 |
| Data, Analytics & IT | 1 |
| Real Estate & Construction | 1 |
| Media & Entertainment | 1 |
| Gaming & eSports | 1 |
| Professional Services | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 1 |
| $5M-$10M | 1 |
| $10M-$25M | 3 |
| $25M-$50M | 4 |
| $50M-$100M | 11 |
| $100M-$250M | 19 |
| $250M-$500M | 1 |
| $500M-$1B | 1 |
| $1B+ | 2 |
Deals By Geography
Top 6 of 6 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 21 |
| China | 11 |
| Europe | 7 |
| Japan | 2 |
| India | 1 |
| Singapore | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| BVF Partners | 4 |
| Cormorant Asset Management | 4 |
| Lilly Asia Ventures | 4 |
| OrbiMed | 4 |
| ArrowMark Partners | 3 |
| Janus Henderson Investors | 3 |
| Legend Capital | 3 |
| Rock Springs Capital | 3 |
| SoftBank | 3 |
| Tencent | 3 |
| Wellington Management | 3 |
| 1955 Capital | 2 |
| AbbVie Ventures | 2 |
| abrdn | 2 |
| Alexandria Venture Investments | 2 |
| Ally Bridge Group | 2 |
| Alumni Ventures | 2 |
| Andreessen Horowitz | 2 |
| Breakthrough Energy Ventures | 2 |
| Canaan Partners | 2 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 20 | 47% |
| Participating | 23 | 53% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 9 | 45% |
| Co-led | 11 | 55% |
Team
Partner
Venture Partner, HH Bioventure
Partner
Chairman, Founder, CEO
Operating GM
Partner & Co-Head of Global Buyout
Operating Partner
Operating Partner